Skip to main content

Table 2 Clinical patient characteristics

From: Late effects of pediatric hematopoietic stem cell transplantation on left ventricular function, aortic stiffness and myocardial tissue characteristics

  Pediatric HSCT recipients (n = 16)
Transplant-related characteristics
Age at time of HSCT, years 7.2 ± 5.3
Time after HSCT, years 14.8 ± 5.0
Malignant disorder, n (%) 10 (62.5%)
 ALL or AML 8
 MDS or CML 2
Non-malignant disorder, n (%) 6 (37.5%)
 Hematological disease 4
 Other 2
Anthracycline therapy, n (%) 7 (43.8%)
 < 300 mg/m2 5
 ≥ 300 mg/m2 2
Radiotherapy, n (%) 8 (50.0%)
 Total body irradiation 7
 Chest irradiation 1
Cyclophosphamide therapy, n (%) 14 (87.6%)
 < 1 g/m2 1
 ≥ 1 g/m2 13
Allogeneic HSCT, n (%) 15 (94%)
 HLA-identical sibling 6
 Other related or unrelated donor 9
Graft versus host disease, n (%) 5 (31.3%)
 Acute 2
 Chronic 3
Clinical parameters
 Systolic blood pressure, mmHg 121 ± 12
 Diastolic blood pressure, mmHg 76 ± 9
 Pulse, beats per minute 75 ± 12
  1. Values are presented as numbers (percentages) or means ± standard deviations. HSCT hematopoietic stem cell transplantation, ALL acute lymphatic leukemia, AML acute myeloid leukemia, MDS myelodysplastic syndrome, CML chronic myeloid leukemia